SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-120303
Filing Date
2023-11-21
Accepted
2023-11-21 14:31:38
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2331305-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2331305-4_4seq1.xml 4 3121
  Complete submission text file 0001104659-23-120303.txt   4544
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 231426800